PDCD1 and glioblastoma: To effectively deliver and target multiple sites within heterogeneous GBM, we designed umbilical cord-UMSCs as bio-based materials, incorporating the therapeutic PD-1 gene on the surface and miR-124 with G1 arrest capacity for GBM treatment.